| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/01/2011 | US7879586 Gene encoding methylated catechin synthase |
| 02/01/2011 | US7879571 Population based assessments and means to rank the relative immunogenicity of proteins |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879540 Nucleotide sequences modified to present reduced transcriptional characteristics subsequent to gene expression |
| 02/01/2011 | US7879338 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 02/01/2011 | US7879337 Mutant porcine reproductive and respiratory syndrome virus |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879328 Antibodies that immunospecifically bind to B lymphocyte stimulator |
| 02/01/2011 | US7879326 Human neutralizing monoclonal antibodies to H5N1 influenza A virus |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879111 System and method for RFID transfer of MAC, keys |
| 02/01/2011 | US7878786 Apparatus for producing tissue scaffold having aligned fibrils |
| 02/01/2011 | CA2541513C Method for preparing artificial cell tissue and substrate therefor |
| 02/01/2011 | CA2522246C Method of producing chondrocytes for transplantation |
| 02/01/2011 | CA2425476C Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/01/2011 | CA2372097C Epoxide hydrolases of aspergillus origin |
| 02/01/2011 | CA2359013C Compositions and methods for packaging of alphavirus vectors |
| 02/01/2011 | CA2345882C Methods and compositions for the prevention and treatment of anemia |
| 02/01/2011 | CA2274902C Submucosa extracts |
| 02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 01/28/2011 | CA2708051A1 Mammalian cell culture media which comprise supernatant from cohn fractionation stages and use thereof |
| 01/27/2011 | WO2011011677A2 Potency markers |
| 01/27/2011 | WO2011011632A1 Methods and compositions for modulating membrane potential to influence cell behavior |
| 01/27/2011 | WO2011011593A1 Identity markers |
| 01/27/2011 | WO2011011477A1 Use of stem cells to reduce leukocyte extravasation |
| 01/27/2011 | WO2011011468A2 Cell-mediated silica sol-gel encapsulation of living cells and tissues |
| 01/27/2011 | WO2011011388A2 Neuregulin induced regeneraton of heart muscle muscle |
| 01/27/2011 | WO2011011349A2 Differentiation of human embryonic stem cells |
| 01/27/2011 | WO2011011302A2 Differentiation of human embryonic stem cells |
| 01/27/2011 | WO2011011300A2 Differentiation of human embryonic stem cells |
| 01/27/2011 | WO2011011055A2 Methods and compositions for improving the viability of cryopreserved cells |
| 01/27/2011 | WO2011010966A1 Pre-natal mesenchymal stem cells |
| 01/27/2011 | WO2011010965A1 Method of using an established cell line for glioma therapy |
| 01/27/2011 | WO2011010485A1 Process for production of eicosanoid, eicosanoid biosynthesis gene derived from marchantia polymorpha, and use of the gene |
| 01/27/2011 | WO2011010449A1 Image processing device, culture observation apparatus, and image processing method |
| 01/27/2011 | WO2011009878A1 Pluripotent stem cells obtained from dental pulp |
| 01/27/2011 | WO2011009706A1 Method for obtaining myofibroblasts |
| 01/27/2011 | WO2011009613A1 Enzymatic composition for the digestion of chicken embryos |
| 01/27/2011 | WO2011009294A1 Methods for obtaining hepatic cells, hepatic endoderm cells and hepatic precursor cells by inducing the differentiation |
| 01/27/2011 | WO2010122044A3 Cell culture carriers for cultivating human stem cells and precursor cells and a method for cultivation |
| 01/27/2011 | WO2010107285A3 Volume production method for growth factor using mesenchymal stem cells derived from the fetus in amniotic fluid |
| 01/27/2011 | WO2010081078A3 Device and non-toxic compositions and methods for permeabilization of drosophila embryos |
| 01/27/2011 | WO2008135837A9 Method and device for non- invasive prenatal diagnosis |
| 01/27/2011 | US20110023194 Engineering zymogen for conditional toxicity |
| 01/27/2011 | US20110023193 Drought and heat tolerance in plants |
| 01/27/2011 | US20110023191 Methods for improving crop plant architecture and yield |
| 01/27/2011 | US20110023190 Use of dimerization domain component stacks to modulate plant architecture |
| 01/27/2011 | US20110023189 Transformed plant with promoted growth |
| 01/27/2011 | US20110023188 Plants having enhanced yield-related traits and a method for making the same |
| 01/27/2011 | US20110023186 Method for modifying plant morphology, biochemistry and physiology |
| 01/27/2011 | US20110023184 Axmi-205 pesticidal gene and methods for its use |
| 01/27/2011 | US20110023183 Switchgrass Promoter and Uses Thereof |
| 01/27/2011 | US20110023182 Enzymes involved in triterpene synthesis |
| 01/27/2011 | US20110023181 Means for Improving Agrobiological Traits in a Plant by Providiing a Plant Cell Comprising in its Chloroplasts Enzymatic Activities for Converting Glycolate Into Malate |
| 01/27/2011 | US20110023180 Novel hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
| 01/27/2011 | US20110023179 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods |
| 01/27/2011 | US20110023178 High threonine producing lines of nicotiana tobacum and methods for producing |
| 01/27/2011 | US20110023177 Genetically Modified Plants Displaying Reduced Accumulation of Cadmium |
| 01/27/2011 | US20110023170 Inbred corn line ab7 |
| 01/27/2011 | US20110023169 Inbred corn line mn8 |
| 01/27/2011 | US20110023167 Soybean variety a1016334 |
| 01/27/2011 | US20110023164 Soybean variety a1015484 |
| 01/27/2011 | US20110023162 Genetically modified chrysanthemums |
| 01/27/2011 | US20110023159 Ovine genome editing with zinc finger nucleases |
| 01/27/2011 | US20110023158 Bovine genome editing with zinc finger nucleases |
| 01/27/2011 | US20110023157 Equine genome editing with zinc finger nucleases |
| 01/27/2011 | US20110023156 Feline genome editing with zinc finger nucleases |
| 01/27/2011 | US20110023154 Silkworm genome editing with zinc finger nucleases |
| 01/27/2011 | US20110023153 Genomic editing of genes involved in alzheimer's disease |
| 01/27/2011 | US20110023152 Genome editing of cognition related genes in animals |
| 01/27/2011 | US20110023151 Genome editing of abc transporters |
| 01/27/2011 | US20110023150 Genome editing of genes associated with schizophrenia in animals |
| 01/27/2011 | US20110023149 Genomic editing of genes involved in tumor suppression in animals |
| 01/27/2011 | US20110023148 Genome editing of addiction-related genes in animals |
| 01/27/2011 | US20110023147 Genomic editing of prion disorder-related genes in animals |
| 01/27/2011 | US20110023146 Genomic editing of genes involved in secretase-associated disorders |
| 01/27/2011 | US20110023145 Genomic editing of genes involved in autism spectrum disorders |
| 01/27/2011 | US20110023144 Genomic editing of genes involved in amyotrophyic lateral sclerosis disease |
| 01/27/2011 | US20110023143 Genomic editing of neurodevelopmental genes in animals |
| 01/27/2011 | US20110023141 Genomic editing of genes involved with parkinson's disease |
| 01/27/2011 | US20110023140 Rabbit genome editing with zinc finger nucleases |
| 01/27/2011 | US20110023139 Genomic editing of genes involved in cardiovascular disease |
| 01/27/2011 | US20110023138 Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster) and non-human mammalian animal retaining the same |
| 01/27/2011 | US20110023137 Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| 01/27/2011 | US20110023136 F1B-TMIR Plasmid Vector and Transgenic Mouse |
| 01/27/2011 | US20110023135 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions |
| 01/27/2011 | US20110022326 Quantitation Method Using Isotope Labeled Internal Standard Substance, Analysis System for Executing the Quantitation Method, and Program for the Analysis |
| 01/27/2011 | US20110021981 Methods And Compositions For Treating Trauma-Hemorrhage Using Estrogen And Derivatives Thereof |
| 01/27/2011 | US20110021757 Transgenic silkworm capable of producing antibody and method for production thereof |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021611 Efficient cell culture system for hepatitis c virus genotype 5a |
| 01/27/2011 | US20110021609 MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia (AML) and Uses Thereof |
| 01/27/2011 | US20110021607 Methods and Compositions Relating to Carcinoma Stem Cells |